Desfesoterodine in the form of a tartaric acid salt

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9085507
APP PUB NO 20120128773A1
SERIAL NO

13319746

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns desfesoterodine in the form of a tartaric acid salt, in particular in the polymorphic “R form”, as well as a process for its production. In a second aspect, the invention concerns the desfesoterodine of the invention in a microencapsulated form.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RATIOPHARM GMBH89079 ULM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Auer, Gertrud Gomaringen, DE 1 0
Brueck, Sandra Munich, DE 22 44
Fischer, Dirk Frankfurt am Main, DE 61 534
Koellner, Gertraud Neu-Ulm, DE 2 0
Muskulus, Frank Laupheim, DE 20 69
Paetz, Jana Bonn, DE 29 62
Rimkus, Katrin Iserlohn, DE 23 51

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 21, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00